This basic science study demonstrates that mitochondrial creatine kinase binds to the surface of cardiolipin membranes, restricting lipid chain mobility without penetrating the hydrophobic region.
Answers are grounded in this paper and cite their sources.
Should not yet change clinical practice; leaves open mitochondrial creatine kinase-cardiolipin interactions in human disease models.
The binding of the mitochondrial creatine kinase to aqueous dispersions of beef heart cardiolipin has been studied via the perturbation of the mobility of spin-labelled cardiolipin, using electron spin resonance (ESR) spectroscopy. In the presence of creatine kinase (1:1 protein/lipid ratio, by mass), the ESR spectra of cardiolipin labelled in a single acyl chain [n-(4,4-dimethyl-oxazolidinyl-N- oxy)stearoylcardiolipin] indicate a restriction of motion both at the C-5 and C-14 positions (n = 5, 14) of the lipid chains. The restriction in mobility was reversed by addition of phosphate or adriamycin, which are thought to inhibit the binding of creatine kinase to the mitochondrial membrane or to displace it from its binding site on the membrane. The effect of the protein on the chain mobility is consistent with surface binding of the protein; no positive evidence was obtained for penetration of the protein into the hydrophobic region of the membrane.
No takes yet. Share an insight, caveat, or question.
Cheneval et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: